Skip to main content
Premium Trial:

Request an Annual Quote

Christine Rousseau

Chembio Diagnostics has appointed Christine Rousseau to the newly created position of vice president of corporate development, effective immediately. She will focus on the company's point-of-care infectious disease diagnostics strategy and execution, including HIV self-testing, and fever and tropical diseases, as well as collaborations leveraging Chembio's DPP technology platform and expertise. Rousseau was previously at the Bill & Melinda Gates Foundation, most recently as senior program officer of Global Health, Integrated Technology Solutions. Prior to that, she was a research scientist and faculty member at the University of Washington.